Cancer glossary
HER2 on an IHC report: what 0, 1+, 2+ and 3+ mean in cancer
How to read HER2 on a breast cancer IHC report: what 0, 1+, 2+ and 3+ mean, why a 2+ result needs FISH, and how HER2 status shapes treatment choices.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026
In short
HER2 is a protein on the cell surface that pushes the cell to divide. Reports grade it on a scale from 0 to 3+: 3+ means HER2-positive, 2+ needs an extra test, and 0 or 1+ means HER2-negative.
How it appears in your report
- ‘HER2/neu: 3+ (complete, intense membrane staining)’ — positive.
- ‘HER2: 2+, ISH recommended’ — not a final result.
- ‘FISH: no HER2 gene amplification’ — after a 2+ result, the tumor is considered HER2-negative.
- ‘HER2: 1+’ or ‘HER2: 0’ — negative, though for metastatic cancer the difference between the two now matters.
What it means
Scoring criteria follow ASCO/CAP, as summarized by the American Cancer Society:
| IHC result | What the pathologist sees | Status |
|---|---|---|
| 0 | no staining, or staining in 10% of cells or fewer | HER2-negative |
| 1+ | faint or incomplete staining in more than 10% of cells | HER2-low |
| 2+ | more complete staining in more than 10% of cells, weaker than 3+ | equivocal, needs FISH |
| 3+ | complete, intense staining in more than 10% of cells | HER2-positive |
About 15–20% of breast cancers are HER2-positive. HER2 is scored only in the invasive part of the tumor.
Does it affect treatment
Yes. HER2-positive cancer is treated with anti-HER2 drugs, usually together with chemotherapy, and with hormone therapy as well if the ER/PR receptors are positive. With HER2 0, these drugs do not work. For 1+ and 2+ tumors without amplification, separate options now exist in metastatic disease — see HER2-low. Which regimen fits depends on stage and subtype, and your treating doctor decides.
Questions to ask your doctor
- If my HER2 is 2+, has ISH been done, and what did it show?
- If I have metastatic cancer and HER2 0, is it worth rechecking for 1+?
- Does HER2 on the biopsy match HER2 on the surgical specimen?
For a detailed walkthrough, see the article on IHC in breast cancer. If the result is borderline, you can get a second opinion.
Sources
- Breast Cancer HER2 Status — American Cancer Society, 2026
- Recommendations for HER2 Testing in Breast Cancer: 2023 Update — College of American Pathologists / ASCO, 2023
- Breast Cancer Biomarker Tests — National Cancer Institute, 2025
Watch me explain this on video
Short videos on my Instagram (in Russian)
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
